Skip to main content
SpringerLink
Log in

Should Folate Supplementation be Routinely Recommended for Older Patients Receiving Methotrexate

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weinblatt ME, Trentham DE, Fraser PA, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988; 31: 167–75

    Article  PubMed  CAS  Google Scholar 

  2. Felson DT, Anderson JJ, Meenan RE The comparative efficacy and toxicity of second line drugs in rheumatoid arthritis: results of two meta-analyses. Arthritis Rheum 1990; 33: 1449–61

    Article  PubMed  CAS  Google Scholar 

  3. Fehlauer CS, Carson CW, Cannon GW, et al. Methotrexate therapy in rheumatoid arthritis: 2-year retrospective follow up study. J Rheumatol 1989; 16: 307–12

    PubMed  CAS  Google Scholar 

  4. Wolfe F, Hawley DJ, Cathey MA. Termination of slow-acting antirheumatic therapy in rheumatoid arthritis: a 14-year pro-spective evaluation of 1017 consecutive starts. J Rheumatol 1990; 17: 994–1002

    PubMed  CAS  Google Scholar 

  5. Poole P, Yeoman S, Caughey D. Methotrexate in older patients with rheumatoid arthritis. Br J Rheumatol 1992; 31: 860–3

    Article  PubMed  CAS  Google Scholar 

  6. Alarcon GS, Tracy IC, Blackburn Jr WD. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989; 32: 671–6

    Article  PubMed  CAS  Google Scholar 

  7. Sperling A, Benimeno I, Arsten KF, et al. Effects of methotrexate on 5-lipoxygenase pathway metabolism of arachidonic acid in rheumatoid arthritis [abstract]. Arthritis Rheum 1990; 33 Suppl.: 173

    Article  Google Scholar 

  8. Segal R, Mozes E, Yaron M, et al. The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989; 32: 370–7

    Article  PubMed  CAS  Google Scholar 

  9. Cronstein BN, Eberle MA, Gruber HE, et al. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991; 88: 2441–5

    Article  PubMed  CAS  Google Scholar 

  10. Morgan SL, Baggot JE, Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum 1987; 30: 1348–55

    Article  PubMed  CAS  Google Scholar 

  11. Kremer JK, Galivan J, Streckfuss A, et al. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 1986; 29: 832–5

    Article  PubMed  CAS  Google Scholar 

  12. Leeb BF, Witzmann G, Ogris E, et al. Folic acid levels in serum and red blood cells of methotrexate treated patients with rheumatoid arthritis and psoriatic arthritis [abstract]. Arthritis Rheum 1992; 35 Suppl.: B191

    Google Scholar 

  13. Weinblatt ME, Fraser P. Elevated mean corpuscular volume as a predictor of hematologie toxicity due to methotrexate therapy. Arthritis Rheum 1989; 32: 1592–6

    Article  PubMed  CAS  Google Scholar 

  14. Buchbinder R, Hall S, Sambrook PN, et al. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 1993; 20: 639–44

    PubMed  CAS  Google Scholar 

  15. Stenger AAME, Houtman PM, Bruyn GA. Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate? Ann Rheum Dis 1992; 51: 1019–20

    Article  PubMed  CAS  Google Scholar 

  16. Tishler M, Caspi D, Fishel B, et al. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum 1988; 31: 906–8

    Article  PubMed  CAS  Google Scholar 

  17. Buckley LM, Vacek PM, Cooper SM. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 1158–61

    PubMed  CAS  Google Scholar 

  18. Shiroky JB, Neville C, Esdaile JM, et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Arthritis Rheum 1993; 36: 795–3

    Article  PubMed  CAS  Google Scholar 

  19. Stewart KA, Mackenzie AH, Clough JD, et al. Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Sem Arthr Rheum 1991; 20: 332–8

    Article  CAS  Google Scholar 

  20. Morgan SL, Baggot JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990; 33: 9–18

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Medicine, Center for Rheumatic Diseases, Lainz Hospital, Wolkersbergenstrasse 1, A-1130, Vienna, Austria

    Burkhard F. Leeb

Authors
  1. Burkhard F. Leeb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leeb, B.F. Should Folate Supplementation be Routinely Recommended for Older Patients Receiving Methotrexate. Drugs & Aging 5, 319–322 (1994). https://doi.org/10.2165/00002512-199405050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199405050-00001

Keywords

Search

Navigation